BRITTANY CHRISTMAS: Open Payments
NPI 1861153462 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 87 payments from 14 companies in 2025. Trend: 2023 $668 · 2024 $1,406 · 2025 $1,384
Food & beverage: $1,384
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 14 | $243 |
| Corium, LLC | 17 | $207 |
| ABBVIE INC. | 19 | $193 |
| Otsuka America Pharmaceutical, Inc. | 11 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $178 |
| Axsome Therapeutics, Inc. | 4 | $110 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Alkermes, Inc. | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
Products named: Qelbree, Azstarys, VRAYLAR, CAPLYTA, Auvelity, REXULTI, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across IN — which companies pay providers there.
